arrow
J

Jacques Simard

Laval University
H指数:98
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation Project

包括多基因评分在内的风险因素对个性化乳腺癌筛查实施的多因素风险评估的贡献:来自PERSPECTIVE:整合与实施项目的见解

Cancers
IF4.4
2026-05-050
OA
Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada

来自加拿大多利益相关方研讨会关于实施乳腺癌风险分层筛查项目的视角

2026-04-210
OAAI
Canadian Women's Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project

加拿大女性对接受个性化乳腺癌风险信息的看法:来自PERSPECTIVE I&I项目的见解

2026-03-012
OA
Genetic counseling services for hereditary breast and ovarian cancer: patients’ experience and satisfaction with different service models

遗传性乳腺癌和卵巢癌的遗传咨询:患者对不同服务模式的体验与满意度

2026-02-160
PRE
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women

基于家族史、多基因风险评分和传统风险模型的乳腺癌高风险分类阈值重叠:一项针对180,398名女性的研究

2025-11-030
OAAI
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers

亚洲BRCA1和BRCA2致病性变异携带者乳腺癌风险的polygenic risk score多基因风险评分

2025-09-300
OA
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK population

将BOADICEA乳腺癌和卵巢癌风险模型适应于英国多民族人口

2025-07-170
OAAI
Genetic discrimination in insurance and employment based on personalized risk stratification for breast cancer screening

基于乳腺癌筛查个性化风险分层的保险和就业中的基因歧视

2025-03-050
OA
Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model (vol 34, pg 205, 2025)

将替代多基因风险评分纳入BOADICEA乳腺癌风险预测模型 (第34卷,205页,2025)

2025-01-090
OAAI
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

褪黑激素生物合成和信号传导基因的多态性支持乳腺癌夜间光照假说

2023-10-033
OAAI
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk (vol 55, pg 1435, 2023)
2023-09-260
OAAI
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
2023-08-1713
OAAI
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
2023-06-275
OAAI
Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening

加拿大医疗保健专业人员对风险分层乳腺癌筛查的看法和态度

2023-06-214
OAAI
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium

BRCA1或BRCA2致病变异携带者的身高,体重指数和体重增加与乳腺癌风险的关联: BRCA1和BRCA2队列联盟

2023-06-206
OAAI
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

意义不确定的变体的功能和临床表征确定了RAD51C中失活错义变体的热点

2023-05-302
OAAI
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

卵巢癌病理特征是BRCA1和BRCA2变异致病性的预测因子

2023-04-198
OA